Lionco Pharmaceutical Group Co Ltd logo

Lionco Pharmaceutical Group Co Ltd

SHSE:603669 (China)  
¥ 4.99 (+0.2%) May 30
On watch
P/E:
At Loss
P/B:
3.21
Market Cap:
¥ 3.60B ($ 508.32M)
Enterprise V:
¥ 3.32B ($ 469.47M)
Volume:
980.20K
Avg Vol (2M):
2.29M
Volume:
980.20K
Market Cap ¥:
3.60B
Market Cap $:
508.32M
PE Ratio:
At Loss
Avg Vol (2M):
2.29M
Enterprise Value ¥:
3.32B
Enterprise Value $:
469.47M
PB Ratio:
3.21

Business Description

Description
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
Name Current Vs Industry Vs History
Cash-To-Debt 1.46
Equity-to-Asset 0.58
Debt-to-Equity 0.61
Debt-to-EBITDA -2.95
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.96
Distress
Grey
Safe
Beneish M-Score -2.37
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -45.4
3-Year Book Growth Rate -5.1
Name Current Vs Industry Vs History
5-Day RSI 45.99
9-Day RSI 43.9
14-Day RSI 42.63
6-1 Month Momentum % -15.11
12-1 Month Momentum % -16.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.19
Quick Ratio 3.02
Cash Ratio 2.67
Days Inventory 198.55
Days Sales Outstanding 186.99
Days Payable 232
Balance Sheet Breakdown
Cashflow Statement Breakdown

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Lionco Pharmaceutical Group Co Ltd Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 236.567
EPS (TTM) (¥) -0.33
Beta 1.41
Volatility % 25.84
14-Day RSI 42.63
14-Day ATR (¥) 0.135958
20-Day SMA (¥) 5.1165
12-1 Month Momentum % -16.48
52-Week Range (¥) 4.81 - 7.63
Shares Outstanding (Mil) 721.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lionco Pharmaceutical Group Co Ltd Filings

Document Form Filing Date
No Filing Data

Lionco Pharmaceutical Group Co Ltd Stock Events

Event Date Price(¥)
No Event Data

Lionco Pharmaceutical Group Co Ltd Frequently Asked Questions

What is Lionco Pharmaceutical Group Co Ltd(SHSE:603669)'s stock price today?
The current price of SHSE:603669 is ¥4.99. The 52 week high of SHSE:603669 is ¥7.63 and 52 week low is ¥4.81.
When is next earnings date of Lionco Pharmaceutical Group Co Ltd(SHSE:603669)?
The next earnings date of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) is .
Does Lionco Pharmaceutical Group Co Ltd(SHSE:603669) pay dividends? If so, how much?
The  Dividend Yield %  of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) is 2% (As of Today), Highest Dividend Payout Ratio of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) was 2.22. The lowest was 0. And the median was 0.68. The  Forward Dividend Yield % of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) is 2%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release